IBN News

Pyoderma Gangrenosum Pipeline Report 2026: Spesolimab Leads in Phase III as IL-36 Blockade Targets Unmet Need

INBRAIN Neuroelectronics and MINIGRAPH European Consortium Develop Magnetically Guided Robotic Implantation for Ultra-Thin Graphene Brain-Computer Interfaces

IBN to Serve as Media Sponsor of Stocktwits’ Stocktoberfest 2026

ICICI Bank Limited Files Annual Report on Form 20-F for Fiscal Year ended March 31, 2026

BluSky AI Inc. Announces IBN as Its Corporate Communications Partner for New Regulation A Offering

Apis Partners anuncia el cierre definitivo de su Fondo III, con 1230 millones de dólares, el doble que su predecesor

Force Factor(R) Launches Super GLP-1(TM) Support Formulas at Food, Drug, and Mass retailers nationwide Featuring Eriomin(R) from Ingredients by Nature

IBN Supercharges Global Investor Reach for The Market Link via InvestorWire

IBN Re-engaged to Provide Real-Time Coverage of the Centri Capital Conference

IBN Announces Latest Episode of The GotStocks Podcast featuring Matthew McKean, CEO of Frontieras North America Inc.